Drugs / Ovcon® 35
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | OVCON-35 | — | 1976-03-29 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01318005 Comparator | Feb 2011 → Jun 2014 | — | University of Southern California | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ovcon 35 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01318005 ↗ |
| Route | Oral | “Oral Contraceptive: Ovcon® 35, pill, 2-3 mos, daily.” NCT01318005 ↗ |